CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024 ...Middle East

SHANGHAI, June 15, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the initial results from the ongoing first-in-human...

Hence then, the article about carsgen presents first in human results of gprc5d targeting car t ct071 at eha 2024 was published today ( Saturday 15/06/2024 - 03:56 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024 )

Also on site :

• UFO Files: 13 Fighter Jets Chased Flying Object, Star-Shaped Entity Seen
• Trump promised no-cost IVF treatment for all. That’s still a long way off
• Eli Lilly says next-generation weight loss drug clears crucial obesity trial